US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 0.263
  • -0.009-3.45%
Close Dec 13 16:00 ET
  • 0.260
  • -0.003-1.07%
Post 20:01 ET
14.50MMarket Cap-0.11P/E (TTM)

Marinus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
16.39%8.54M
32.48%8.06M
-26.02%7.68M
21.63%30.99M
0.39%7.19M
213.59%7.34M
239.72%6.08M
-26.83%10.38M
66.03%25.48M
371.18%7.16M
Operating revenue
16.39%8.54M
32.48%8.06M
-26.02%7.68M
21.63%30.99M
0.39%7.19M
213.59%7.34M
239.72%6.08M
-26.83%10.38M
66.03%25.48M
371.18%7.16M
Cost of revenue
56.92%714K
90.41%735K
266.99%756K
468.82%1.93M
203.77%887K
847.92%455K
386K
206K
-77.00%340K
292K
Gross profit
13.71%7.83M
28.55%7.32M
-31.95%6.92M
15.58%29.06M
-8.25%6.3M
200.31%6.88M
218.16%5.7M
-28.28%10.17M
81.28%25.14M
351.97%6.87M
Operating expense
-24.97%28.91M
1.27%37.61M
-0.91%42.74M
16.40%160.54M
15.68%41.74M
18.95%38.53M
-3.69%37.13M
39.62%43.14M
24.48%137.93M
26.00%36.08M
Selling and administrative expenses
-15.44%12.57M
6.28%16.71M
22.51%18.63M
7.58%61.15M
4.78%15.36M
11.05%14.87M
-7.85%15.72M
29.54%15.2M
52.49%56.85M
38.00%14.66M
Research and development costs
-30.97%16.33M
-2.41%20.9M
-13.66%24.12M
24.37%99.39M
23.14%26.38M
24.52%23.66M
-0.39%21.41M
55.26%27.93M
8.69%79.91M
18.93%21.42M
Other operating expenses
----
----
----
----
----
----
----
----
--1.17M
--0
Operating profit
33.39%-21.08M
3.67%-30.29M
-8.67%-35.82M
-16.58%-131.49M
-21.31%-35.44M
-5.14%-31.65M
14.49%-31.44M
-97.25%-32.96M
-16.36%-112.79M
-7.73%-29.21M
Net non-operating interest income expense
-38.26%-3.25M
-68.65%-3.51M
-59.87%-2.88M
-5.58%-8.78M
-31.09%-2.55M
-10.71%-2.35M
19.13%-2.08M
-7.38%-1.8M
-232.45%-8.32M
-27.19%-1.95M
Non-operating interest income
-68.44%598K
-47.89%1.11M
-37.60%1.46M
244.65%8.11M
0.17%1.75M
268.68%1.9M
2,433.33%2.13M
19,425.00%2.34M
2,842.50%2.35M
7,482.61%1.74M
Non-operating interest expense
-9.41%3.84M
9.72%4.62M
4.80%4.35M
58.31%16.9M
16.48%4.3M
61.05%4.24M
58.43%4.21M
145.09%4.15M
313.32%10.67M
137.60%3.69M
Other net income (expense)
-90.21%100K
-4,427.66%-2.03M
-2.70%36K
-102.56%-2.68M
-149.24%-3.78M
-99.05%1.02M
149.47%47K
103.81%37K
15,832.88%104.68M
-544.87%-1.52M
Special income (charges)
--0
---1.95M
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
--0
--1.95M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-90.21%100K
-278.72%-84K
-2.70%36K
-102.56%-2.68M
-149.24%-3.78M
-99.05%1.02M
149.47%47K
103.81%37K
15,832.88%104.68M
-544.87%-1.52M
Income before tax
26.53%-24.23M
-7.04%-35.83M
-11.34%-38.67M
-770.17%-142.94M
-27.83%-41.77M
-143.94%-32.97M
15.12%-33.47M
-79.38%-34.73M
83.37%-16.43M
-15.44%-32.68M
Income tax
0
0
-145.38%-1.54M
0
0
-1.54M
3.39M
1.64M
Net income
26.53%-24.23M
-12.19%-35.83M
-11.34%-38.67M
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
Net income continuous Operations
26.53%-24.23M
-12.19%-35.83M
-11.34%-38.67M
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
Minority interest income
Net income attributable to the parent company
26.53%-24.23M
-12.19%-35.83M
-11.34%-38.67M
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.53%-24.23M
-12.19%-35.83M
-11.34%-38.67M
-613.59%-141.41M
-22.94%-41.77M
-146.03%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-20.04%-33.98M
Basic earnings per share
31.15%-0.42
-3.28%-0.63
-1.49%-0.68
-415.69%-2.63
2.63%-0.74
-131.61%-0.61
42.45%-0.61
-28.85%-0.67
81.04%-0.51
1.30%-0.76
Diluted earnings per share
31.15%-0.42
-3.28%-0.63
-1.49%-0.68
-415.69%-2.63
2.63%-0.74
-132.28%-0.61
42.45%-0.61
-28.85%-0.67
81.04%-0.51
1.30%-0.76
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 16.39%8.54M32.48%8.06M-26.02%7.68M21.63%30.99M0.39%7.19M213.59%7.34M239.72%6.08M-26.83%10.38M66.03%25.48M371.18%7.16M
Operating revenue 16.39%8.54M32.48%8.06M-26.02%7.68M21.63%30.99M0.39%7.19M213.59%7.34M239.72%6.08M-26.83%10.38M66.03%25.48M371.18%7.16M
Cost of revenue 56.92%714K90.41%735K266.99%756K468.82%1.93M203.77%887K847.92%455K386K206K-77.00%340K292K
Gross profit 13.71%7.83M28.55%7.32M-31.95%6.92M15.58%29.06M-8.25%6.3M200.31%6.88M218.16%5.7M-28.28%10.17M81.28%25.14M351.97%6.87M
Operating expense -24.97%28.91M1.27%37.61M-0.91%42.74M16.40%160.54M15.68%41.74M18.95%38.53M-3.69%37.13M39.62%43.14M24.48%137.93M26.00%36.08M
Selling and administrative expenses -15.44%12.57M6.28%16.71M22.51%18.63M7.58%61.15M4.78%15.36M11.05%14.87M-7.85%15.72M29.54%15.2M52.49%56.85M38.00%14.66M
Research and development costs -30.97%16.33M-2.41%20.9M-13.66%24.12M24.37%99.39M23.14%26.38M24.52%23.66M-0.39%21.41M55.26%27.93M8.69%79.91M18.93%21.42M
Other operating expenses ----------------------------------1.17M--0
Operating profit 33.39%-21.08M3.67%-30.29M-8.67%-35.82M-16.58%-131.49M-21.31%-35.44M-5.14%-31.65M14.49%-31.44M-97.25%-32.96M-16.36%-112.79M-7.73%-29.21M
Net non-operating interest income expense -38.26%-3.25M-68.65%-3.51M-59.87%-2.88M-5.58%-8.78M-31.09%-2.55M-10.71%-2.35M19.13%-2.08M-7.38%-1.8M-232.45%-8.32M-27.19%-1.95M
Non-operating interest income -68.44%598K-47.89%1.11M-37.60%1.46M244.65%8.11M0.17%1.75M268.68%1.9M2,433.33%2.13M19,425.00%2.34M2,842.50%2.35M7,482.61%1.74M
Non-operating interest expense -9.41%3.84M9.72%4.62M4.80%4.35M58.31%16.9M16.48%4.3M61.05%4.24M58.43%4.21M145.09%4.15M313.32%10.67M137.60%3.69M
Other net income (expense) -90.21%100K-4,427.66%-2.03M-2.70%36K-102.56%-2.68M-149.24%-3.78M-99.05%1.02M149.47%47K103.81%37K15,832.88%104.68M-544.87%-1.52M
Special income (charges) --0---1.95M--------------0--0------------
-Less：Restructuring and merger&acquisition --0--1.95M--------------0--0------------
Other non- operating income (expenses) -90.21%100K-278.72%-84K-2.70%36K-102.56%-2.68M-149.24%-3.78M-99.05%1.02M149.47%47K103.81%37K15,832.88%104.68M-544.87%-1.52M
Income before tax 26.53%-24.23M-7.04%-35.83M-11.34%-38.67M-770.17%-142.94M-27.83%-41.77M-143.94%-32.97M15.12%-33.47M-79.38%-34.73M83.37%-16.43M-15.44%-32.68M
Income tax 00-145.38%-1.54M00-1.54M3.39M1.64M
Net income 26.53%-24.23M-12.19%-35.83M-11.34%-38.67M-613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M
Net income continuous Operations 26.53%-24.23M-12.19%-35.83M-11.34%-38.67M-613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M
Minority interest income
Net income attributable to the parent company 26.53%-24.23M-12.19%-35.83M-11.34%-38.67M-613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.53%-24.23M-12.19%-35.83M-11.34%-38.67M-613.59%-141.41M-22.94%-41.77M-146.03%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-20.04%-33.98M
Basic earnings per share 31.15%-0.42-3.28%-0.63-1.49%-0.68-415.69%-2.632.63%-0.74-131.61%-0.6142.45%-0.61-28.85%-0.6781.04%-0.511.30%-0.76
Diluted earnings per share 31.15%-0.42-3.28%-0.63-1.49%-0.68-415.69%-2.632.63%-0.74-132.28%-0.6142.45%-0.61-28.85%-0.6781.04%-0.511.30%-0.76
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+24.43%
Taiwan Semiconductor
TSM
+4.98%
Tesla
TSLA
+4.34%
ASML Holding
ASML
+0.77%
Qualcomm
QCOM
+0.18%

Unlock the Full List